Patent Assignment
Reel/Frame 039590/0239
Security Interest
Recorded: 2016-08-30
Pages: 16
Assignor
HERON THERAPEUTICS, INC.
Executed: 2016-08-05
Assignee
TANG CAPITAL PARTNERS, LP
4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(35)
Long-Acting Polymeric Delivery Systems
PCT:
PCT/US2015/026695 ↗
Compositions of a Polyorthoester and an Organic Acid Excipient
PCT:
PCT/US2015/026720 ↗
Emulson Formulations of Aprepitant
PCT:
PCT/US2015/051050 ↗
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
PCT:
PCT/US2016/015992 ↗
Methods and Compositions for Topical Delivery of Retinoic Acid
Patent:
5,955,109 →
Application:
08/079,220 →
Peg-Poe, Peg-Poe-Peg, and Poe-Peg-Poe Block Copolymers
Patent:
5,939,453 →
Application:
09/090,648 →
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
Bioerodible Polyorthoesters from Dioxolane-Based Diketene Acetals
Method of Preparing Di(Ketene Acetals)
Bioerodible Poly (Orthoesters)from Dioxolane-Based Diketene Acetals
Pharmaceutical Compositions Using Semi-Solid Delivery Vehicle
Pharmaceutical Compositions Using Semi-Solid Delivery Vehicle
Bioerodible Poly(Ortho Esters) from Dioxane-Based Di(Ketene Acetals), and Block Copolymers Containing Them
Peg-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions for Delivery of Granisetron
Methods of Treating Emesis Utilizing Semi-Solid Delivery Pharmaceutical Compositions Comprising Granisetron
Process for Preparing a Semi-Solid Delivery Vehicle Comprising Granisetron
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions for Delivery of Granisetron
Compositions of a Polyorthoester and an Aprotic Solvent
Compositions of a Polyorthoester and an Aprotic Solvent
Compositions of a Polyorthoester and an Aprotic Solvent
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
Application:
14/253,615 →
Publication:
US 2014/0371187
Compositions and Methods for Injection of a Biodegradable Polymer-Based Delivery System
Application:
14/264,489 →
Publication:
US 2014/0323517
Pharmaceutical Composition Comprising Antiemetic Compounds and Polyorthoester
Application:
14/652,070 →
Publication:
US 2015/0320866
Long-Acting Polymeric Delivery Systems
Compositions of a Polyorthoester and an Organic Acid Excipient
Method of Treating Patients Non-Responsive to Palonosetron
Application:
14/765,179 →
Publication:
US 2015/0359897
Emulsion Formulations of Aprepitant
Methods for Enhancing Stability of Polyorthoesters and Their Formulations
Application:
14/946,493 →
Publication:
US 2016/0144039
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
Emulsion Formulations of Aprepitant
Polymer-Based Compositions for Extended Release of Proteins
Application:
15/108,986 →
Publication:
US 2016/0324798
Emulsion Formulations of Aprepitant
Application:
62/052,948 →
Long-Acting Polymeric Delivery Systems
Application:
62/341,557 →
Powered Delivery Device
Application:
62/360,875 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 3, 2014
From: A.P. PHARMA, INC.
To: HERON THERAPEUTICS, INC.
Reel/Frame 032153/0273 →
Assignment of Assignor's Interest
May 12, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 032872/0480 →
Assignment of Assignor's Interest
May 22, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN; NIEMANN, JOSEPH
To: HERON THERAPEUTICS, INC.
Reel/Frame 032953/0273 →
Release of Security Interest
Oct 20, 2014
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: A.P. PHARMA, INC.
Reel/Frame 033983/0126 →
Release of Security Interest
Mar 25, 2021
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC.
Reel/Frame 055725/0523 →
Intellectual Property Security Agreement
Aug 9, 2023
From: HERON THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 064546/0453 →
Release of Security Interest in Patents Recorded at Reel 026177/Frame 0874
Sep 27, 2023
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.)
Reel/Frame 065045/0730 →